Company Filing History:
Years Active: 2003-2013
Title: Mark J Krantz: Innovator in Vaccine Development
Introduction
Mark J Krantz is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of immunology, particularly in vaccine development. With a total of 3 patents, his work focuses on modulating immune responses to enhance vaccine efficacy.
Latest Patents
One of his latest patents is a vaccine for modulating between T1 and T2 immune responses. This invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo. This innovative approach aims to improve the effectiveness of vaccines in eliciting the desired immune response.
Career Highlights
Throughout his career, Mark has worked with several prominent companies in the biotechnology sector. Notable among these are Oncothyreon Inc. and Biomira, Inc. His experience in these organizations has contributed to his expertise in vaccine research and development.
Collaborations
Mark has collaborated with several professionals in his field, including B Michael Longenecker and Wladyslaw A Budzynski. These collaborations have further enriched his research and innovation efforts.
Conclusion
Mark J Krantz is a distinguished inventor whose work in vaccine development has the potential to significantly impact public health. His innovative patents and collaborations reflect his commitment to advancing immunological research.